Search
中/EN
Contact/Message
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
Search
Home
central pharmacy
Policies
Medical Institution
Franchise
Innovate
Recruit
News
中/EN
Contact/Message
Innovate
Your current position:
Home
Innovate
International innovative drugs
Amvuttra
Amvuttra
departments:
内科
drug:
注射剂
Active:
vutrisiran
indication:
治疗遗传性经甲状腺素介导的淀粉样变多发性神经病
Licensor:
Alnylam
Approved Country/Region:
FDA
Approval time:
2022-06-13